Skip to main content

ArcARoma AB: 210318 ArcAroma achieves technological breakthrough in world market for health drinks – cold-pressed green tea

Press release 2021-03-18ArcAroma’s juiceCEPT® application, which was developed for the treatment of fruit and vegetable juices, has now been evaluated as an improving part of the production of cold-pressed green tea. Tests in ArcAroma’s own lab show that the cold brewing time can be reduced from 24 hours to 30 minutes by using CEPT® – with retained antioxidant qualities.– We are proud that we can demonstrate so many positive effects by using our treatment on cold-pressed green tea – it is a success for juiceCEPT®. Our evaluation shows that we can significantly reduce the cold brewing time, while maintaining the natural taste and all the positive qualities from the antioxidants. The market for cold-pressed green tea has great potential and our new application area has already been received with great interest, not least in China, says Johan Möllerström, CEO of ArcAroma.Tea is the drink most consumed in the world after water – over two billion cups of tea are consumed every day. The global tea market had sales of more than USD 52 billion in 2018 and is expected to exceed USD 81 billion by 2026. In China, which is the world’s largest market for green tea, approximately 300,000 tonnes of green tea are consumed per year.ArcAroma’s CEPT® technology has been shown to have several positive effects on the cold brewing process for green tea. Green tea differs from other types of tea in that it is not fermented or heated, which means that the tea leaves’ vitamins, antioxidants and positive qualities are preserved. ArcAroma’s evaluation is summarized as follows:• Extraction of polyphenols > 500 mg / liter
• Enhanced extraction of Vitamin C
• Less bitter tannins are extracted
• The tea’s natural taste, aromas and sweetness are maintained
• Cold brewing time is reduced from 24 hours to 30 minutes
• The treatment adds a minimal temperature increase of no more than 6° Celsius
For more information, please contact:
Johan Möllerström, CEO
(+46) 768 – 86 81 78
johan.mollerstrom@arcaroma.com
About ArcAroma AB (publ)
ArcAroma has developed a patented technology that controls and applies electrical pulses to optimize various biological processes. The CEPT® platform, which is a high-voltage generator combined with a treatment chamber, uses the technology within FoodTech for increased extraction from the raw material and extended shelf-life and increased quality of the final product. Within CleanTech, the CEPT® platform is used for sewage sludge treatment and biogas production. The platform uses short-term high-voltage pulses (PEF) that crush the cell membrane and eliminate unwanted microorganisms.
Our vision is to contribute to a sustainable world by offering efficient green cutting-edge technology that is easy to use in the areas of FoodTech and CleanTech.
ArcAroma’s shares are listed on NASDAQ First North Premier Growth Market. Erik Penser Bank is Certified Adviser and is available at 08-463 80 00 or certifiedadviser@penser.sewww.arcaroma.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.